http://www.fpnotebook.com/
Second Generation Broad-spectrum CephalosporinsAka: Second Generation Cephalosporins, Cefuroxime, Loracarbef, Cefprozil, Lorabid, Cefzil, Ceftin
- See Also
- Coverage
- Indications
- Respiratory tract infections
- Acute Sinusitis
- Otitis Media
- Preparations
- Loracarbef (Lorabid)
- Adult: 200 to 400 mg po bid
- Child
- Otitis Media: 30 mg/kg/day divided bid
- Other infections: 15 mg/kg/day divided bid
- Directions
- Take more than 1 hour before or 2 hours after food
- Cefprozil (Cefzil)
- Adult: 250 to 500 mg PO divided qd to bid
- Child
- Otitis Media: 15 mg/kg/dose PO bid
- Pharyngitis: 7.5 mg/kg/dose PO bid for 10 days
- Cefuroxime (Ceftin, Zinacef)
- Adult
- Parenteral: 750 to 1500 mg IM or IV every 8 hours
- Oral: 250 to 500 mg PO bid
- Child
- Parenteral: 50-100 mg/kg/day IV divided q6-8 hours
- Oral: 20-30 mg/kg/day PO divided bid
- Reported to have unpleasant taste
- Directions
- Take with food
- Adult
- Cefaclor (Ceclor)
- Listed for historical reference only
- Risk of significant serum-sickness type reaction
- Loracarbef (Lorabid)
Cefuroxime (C0007562) | |
|---|---|
| Definition (MSH) | Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS. |
| Concepts | Organic Chemical (T109) , Antibiotic (T195) |
| MSH | D002444 |
| English | Cefuroxime, CEFUROXIME PREPARATION, Cephuroxime |
| Spanish | cefuroxima |
| Parent Concepts | Cefotaxime (C0007554), Cephalosporins (C0007732), Second generation cephalosporin (C0304319) |
| Sources | LCH, LNC, MSH, MTHSPL, NCI, NDFRT, RXNORM, SCTSPA, SNOMEDCT, USPMG, VANDF Derived from the NIH UMLS (Unified Medical Language System) |
cefprozil (C0053882) | |
|---|---|
| Definition (NCI) | A semi-synthetic cephalosporin and a beta-lactam antibiotic with bactericidal activity. Cefprozil's effect is dependent on its binding to penicillin-binding proteins (PBPs) located in the bacterial cytoplasmic membrane. Binding results in the inhibition of the transpeptidase enzymes, thereby preventing cross-linking of the pentaglycine bridge with the fourth residue of the pentapeptide and interrupting consequent synthesis of peptidoglycan chains. As a result, cefprozil inhibits bacterial septum and cell wall synthesis formation. |
| Concepts | Organic Chemical (T109) , Antibiotic (T195) |
| MSH | C052018 |
| English | cefprozil, CEFPROZIL PREPARATION |
| Spanish | cefprozil, cefprozilo |
| Parent Concepts | Cephalosporins (C0007732), Second generation cephalosporin (C0304319), Unclassified Ingredients (C1372954) |
| Sources | LNC, MSH, MTHSPL, NCI, NDFRT, RXNORM, SCTSPA, SNOMEDCT, USPMG, VANDF Derived from the NIH UMLS (Unified Medical Language System) |
loracarbef (C0065295) | |
|---|---|
| Definition (NCI) | A semi-synthetic, broad-spectrum, beta-lactamase resistant, second-generation cephalosporin antibiotic derived from cephasporium. The bactericidal activity of loracarbef results from the inhibition of bacterial cell wall synthesis through interference with the cross-linking of peptidoglycan units. This results in a reduction of cell wall stability and causes cell lysis. Loracarbef is more active against a variety of gram-negative organisms but less active against gram-positive pathogens compared to first-generation agents. |
| Concepts | Organic Chemical (T109) , Antibiotic (T195) |
| MSH | C054920 |
| English | Carbacefaclor, loracarbef, LORACARBEF PREPARATION, Loracarbef product |
| Spanish | carbacefaclor, loracarbef, producto con loracarbef |
| Parent Concepts | Cephalosporins (C0007732), [AM130] BETA-LACTAMS ANTIMICROBIALS, OTHER (C0973478), Unclassified Ingredients (C1372954), Second generation cephalosporin (C0304319), carbacephems (C0054638) |
| Sources | LNC, MSH, MTHSPL, NCI, NDFRT, RXNORM, SCTSPA, SNOMEDCT, USPMG, VANDF Derived from the NIH UMLS (Unified Medical Language System) |
Ceftin (C0719197) | |
|---|---|
| Concepts | Organic Chemical (T109) , Antibiotic (T195) |
| MSH | C040738 |
| English | Ceftin |
| Sources | MSH, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
Lorabid (C0721422) | |
|---|---|
| Concepts | Organic Chemical (T109) , Antibiotic (T195) |
| MSH | C054920 |
| English | Lilly Brand of Loracarbef Monohydrate, Lorabid, Monarch Brand of Loracarbef Monohydrate |
| Sources | MSH, MTH, NCI, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
Cefzil (C0728743) | |
|---|---|
| Concepts | Organic Chemical (T109) , Antibiotic (T195) |
| MSH | C052018 |
| English | Bristol-Myers Squibb brand of cefprozil, Cefzil |
| Sources | MSH, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
